Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
13/11/2024 | 22:51 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:NAII | Natural Alternatives International Inc |
13/11/2024 | 22:30 | GlobeNewswire Inc. | Natural Alternatives International, Inc. Announces 2025 Q1 Results | NASDAQ:NAII | Natural Alternatives International Inc |
24/10/2024 | 23:50 | GlobeNewswire Inc. | CarnoSyn® Brands Announces New U.S. Distribution Agreement With B&D Nutritional Ingredients | NASDAQ:NAII | Natural Alternatives International Inc |
23/10/2024 | 22:15 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | NASDAQ:NAII | Natural Alternatives International Inc |
28/09/2024 | 01:20 | GlobeNewswire Inc. | Natural Alternatives International, Inc. Announces Fiscal 2024 Q4 and YTD Results | NASDAQ:NAII | Natural Alternatives International Inc |
27/09/2024 | 23:27 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:NAII | Natural Alternatives International Inc |
26/08/2024 | 14:00 | GlobeNewswire Inc. | CarnoSyn® Brands Showcasing TriBsyn™ at the 46th ESPEN Congress On Clinical Nutrition & Metabolism | NASDAQ:NAII | Natural Alternatives International Inc |
07/08/2024 | 14:00 | GlobeNewswire Inc. | CarnoSyn® Brands Unveils TriBsyn™ - “The World’s First Paresthesia-Free Beta-Alanine Powder” | NASDAQ:NAII | Natural Alternatives International Inc |
14/05/2024 | 22:30 | GlobeNewswire Inc. | Natural Alternatives International, Inc. Announces Fiscal 2024 Q3 and YTD Results | NASDAQ:NAII | Natural Alternatives International Inc |
02/04/2024 | 15:00 | GlobeNewswire Inc. | Natural Alternatives International Scheduled to Reopen U.S. Manufacturing Facility in California to Support Increased Production Needs | NASDAQ:NAII | Natural Alternatives International Inc |
11/03/2024 | 23:01 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:NAII | Natural Alternatives International Inc |
15/02/2024 | 17:00 | GlobeNewswire Inc. | CarnoSyn® Brands Partners With Barentz for Exclusive Brazilian Distribution of CarnoSyn® Beta-Alanine | NASDAQ:NAII | Natural Alternatives International Inc |
13/02/2024 | 22:30 | GlobeNewswire Inc. | Natural Alternatives International, Inc. Announces 2024 Q2 and YTD Results | NASDAQ:NAII | Natural Alternatives International Inc |
13/02/2024 | 16:37 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:NAII | Natural Alternatives International Inc |
09/11/2023 | 23:01 | PR Newswire (US) | Natural Alternatives International, Inc. Announces 2024 Q1 Results | NASDAQ:NAII | Natural Alternatives International Inc |
21/09/2023 | 22:15 | PR Newswire (US) | Natural Alternatives International, Inc. Announces 2023 Q4 and YTD Results | NASDAQ:NAII | Natural Alternatives International Inc |
16/08/2023 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NAII | Natural Alternatives International Inc |
16/08/2023 | 22:15 | PR Newswire (US) | Natural Alternatives International, Inc. Announces Temporary Plant Closure and Employee Furloughs | NASDAQ:NAII | Natural Alternatives International Inc |
25/07/2023 | 15:00 | PR Newswire (US) | Natural Alternatives International Appoints New VP of Global Sales | NASDAQ:NAII | Natural Alternatives International Inc |
31/05/2023 | 16:00 | PR Newswire (US) | SR CarnoSyn® Sustained Release Beta-Alanine Selected as Finalist for Ingredient of the Year in Healthy Aging and Cognitive Function by NutraIngredients-USA Awards 2023 | NASDAQ:NAII | Natural Alternatives International Inc |
24/05/2023 | 16:00 | PR Newswire (US) | Natural Alternatives International Strengthens Capabilities by Adding New U.S. Manufacturing Facility in California | NASDAQ:NAII | Natural Alternatives International Inc |
17/05/2023 | 19:30 | PR Newswire (US) | Researchers Behind Recent Publication on SR CarnoSyn® Beta-Alanine Tablet's Ability to Improve Cognitive Health Presenting at American College of Sports Medicine and Exercise Science (ACSM) 2023 Annual Meeting | NASDAQ:NAII | Natural Alternatives International Inc |
15/05/2023 | 22:30 | PR Newswire (US) | Natural Alternatives International, Inc. Announces 2023 Q3 and YTD Results | NASDAQ:NAII | Natural Alternatives International Inc |
15/05/2023 | 22:27 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:NAII | Natural Alternatives International Inc |
23/02/2023 | 14:00 | PR Newswire (US) | NEWLY PUBLISHED STUDY SHOWS SR CARNOSYN® BETA-ALANINE IMPROVES COGNITIVE FUNCTION IN OLDER ADULTS | NASDAQ:NAII | Natural Alternatives International Inc |
10/02/2023 | 23:07 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:NAII | Natural Alternatives International Inc |
08/02/2023 | 22:30 | PR Newswire (US) | Natural Alternatives International, Inc. Announces 2023 Q2 and YTD Results | NASDAQ:NAII | Natural Alternatives International Inc |
06/12/2022 | 12:02 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:NAII | Natural Alternatives International Inc |
05/12/2022 | 22:15 | PR Newswire (US) | Natural Alternatives International, Inc. Announces a $1 Million Increase in its Stock Repurchase Plan | NASDAQ:NAII | Natural Alternatives International Inc |
09/11/2022 | 22:59 | PR Newswire (US) | Natural Alternatives International, Inc. Announces 2023 Q1 Results | NASDAQ:NAII | Natural Alternatives International Inc |